1. Uveitic Macular Edema Nihal Elshakankiry, MD, PhD Professor of Ophthalmology Rowayda M. Amin, MSc Assistant Lecturer of Ophthalmology Alexandria University

2. History 11 year old girl complaining of diminution of vision in her OD 1 month prior to presentation 11 year old girl complaining of diminution of vision in her OD 1 month prior to presentation diagnosed with JIA associated uveitis at the age of 5 years diagnosed with JIA associated uveitis at the age of 5 years was on MTX 15mg/wk and topical steroids bid OU was on MTX 15mg/wk and topical steroids bid OU had cataract surgery OD at the age of 9 years had cataract surgery OD at the age of 9 years

3. First presentation  OD:  BCVA: 6/36  AC +0.5 cell, minimal flare  Pseudophakia  Fundus:  Normal disc and vessels  Thickened macula with blunted foveal reflex?  Uveitic macular edema?

4. First presentation OS: OS: BCVA: 6/9 BCVA: 6/9 Trace AC cell, mild flare Trace AC cell, mild flare Posterior synechae Posterior synechae Normal fundus Normal fundus

5. OCT OD-First presentation Cystoid macular edema Cystoid macular edema 472 microns 472 microns

6. Treatment Bump up topical steroids to qid Bump up topical steroids to qid Posterior subtenon steroid injection OD Posterior subtenon steroid injection OD

7. Posterior subtenon steroid injection

8. After One Month OD: 463 microns OD: 463 microns BCVA 6/36 BCVA 6/36 OS: 390 microns OS: 390 microns BCVA 6/18 BCVA 6/18

9. After 3 Months 303 microns 303 microns BCVA 6/9 BCVA 6/9

10. After 5 Months 301 microns 301 microns BCVA 6/9 BCVA 6/9

11. Conclusion  Uveitic macular edema is a vision compromising complication that should be considered despite achieving remission with appropriate immunomodulatory treatment.  It is associated with certain uveitic entities including: JIA, BCR, Behcet’s disease. JIA, BCR, Behcet’s disease.  Adjunctive steroid therapy is often warranted for treatment.